NYSE:BMYPharmaceuticals
A Look At Bristol Myers Squibb (BMY) Valuation As Recent Results Shape Growth And Cost Outlook
Bristol-Myers Squibb (BMY) has been drawing attention after recent share price moves, with the stock down over the past week and month but showing a gain in the past 3 months.
See our latest analysis for Bristol-Myers Squibb.
Against that backdrop, the recent 3 month share price return of 6.07% and year to date share price return of 7.52% contrast with a 1 year total shareholder return of a 1.12% decline. This suggests momentum has improved recently but remains mixed over a longer horizon.
If...